SCHEMBL6344476

SCHEMBL6344476

CCCCOc1c2ccccc2nc2c1c(C)nn2-c1ccccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.48
MAPT P10636 6/20 0.48
KDM4E B2RXH2 5/20 0.48
HPGD P15428 5/20 0.48
GAA P10253 3/20 0.48
HTT P42858 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
USP2 O75604 1/20 0.44
TSHR P16473 1/20 0.44
LMNA P02545 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.38
NPY1R P25929 1/20 0.38
NPY2R P49146 1/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SPR P35270 4/20 0.37
PTGS2 P35354 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6351852 0.94 ALDH1A1 (0.48) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6343952 0.90 ALDH1A1 (0.53) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6351846 0.86 ALDH1A1 (0.52) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6351185 0.85 ALDH1A1 (0.46) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6351791 0.84 ALDH1A1 (0.47) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6344781 0.83 KDM4E (0.46) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6342649 0.82 ALDH1A1 (0.45) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6343768 0.82 SLC2A1 (0.46) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6351683 0.82 ALDH1A1 (0.50) ALDH1A1MAPTKDM4EHPGDGAA
SCHEMBL6339590 0.81 ALDH1A1 (0.45) ALDH1A1MAPTKDM4EHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949648-B2 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-27 US disclosed
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1270572-A1 CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof PTGS1, PTGIS, IL5 ALDH1A1 1061/4885MAPT 3408/4885KDM4E 1741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.